Celonic Group Signs Long-Term Multi-Year Manufacturing Service Agreement with LINDIS Biotech for the Commercial Supply of Catumaxomab
LINDIS Biotech has received an EMA Marketing Authorization for catumaxomab, making it the only drug approved for the specific and...